Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00132184Phase 3Unknown
Phase 3, randomised, double-blind trial in Crohn's disease comparing Vitamin D with Placebo (2 arms). Primary endpoint: Relapse rate within 1 year treatment; CDAI>220. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00132184.